1. Home
  2. VSEE vs BIAF Comparison

VSEE vs BIAF Comparison

Compare VSEE & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEE
  • BIAF
  • Stock Information
  • Founded
  • VSEE 2008
  • BIAF 2014
  • Country
  • VSEE United States
  • BIAF United States
  • Employees
  • VSEE N/A
  • BIAF N/A
  • Industry
  • VSEE
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VSEE
  • BIAF Health Care
  • Exchange
  • VSEE NYSE
  • BIAF Nasdaq
  • Market Cap
  • VSEE 20.1M
  • BIAF 21.4M
  • IPO Year
  • VSEE N/A
  • BIAF 2022
  • Fundamental
  • Price
  • VSEE $1.36
  • BIAF $1.33
  • Analyst Decision
  • VSEE
  • BIAF Strong Buy
  • Analyst Count
  • VSEE 0
  • BIAF 1
  • Target Price
  • VSEE N/A
  • BIAF $6.00
  • AVG Volume (30 Days)
  • VSEE 1.2M
  • BIAF 220.8K
  • Earning Date
  • VSEE 11-26-2024
  • BIAF 11-14-2024
  • Dividend Yield
  • VSEE N/A
  • BIAF N/A
  • EPS Growth
  • VSEE N/A
  • BIAF N/A
  • EPS
  • VSEE N/A
  • BIAF N/A
  • Revenue
  • VSEE $6,161,959.00
  • BIAF $7,315,883.00
  • Revenue This Year
  • VSEE N/A
  • BIAF $302.41
  • Revenue Next Year
  • VSEE N/A
  • BIAF $15.00
  • P/E Ratio
  • VSEE N/A
  • BIAF N/A
  • Revenue Growth
  • VSEE N/A
  • BIAF 30185.99
  • 52 Week Low
  • VSEE $1.12
  • BIAF $1.21
  • 52 Week High
  • VSEE $33.08
  • BIAF $3.62
  • Technical
  • Relative Strength Index (RSI)
  • VSEE N/A
  • BIAF 43.48
  • Support Level
  • VSEE N/A
  • BIAF $1.21
  • Resistance Level
  • VSEE N/A
  • BIAF $1.37
  • Average True Range (ATR)
  • VSEE 0.00
  • BIAF 0.07
  • MACD
  • VSEE 0.00
  • BIAF 0.01
  • Stochastic Oscillator
  • VSEE 0.00
  • BIAF 70.45

About VSEE VSEE HEALTH INC

VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: